Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Reis

Showing results (391-400 of 415) with videos related to

Pageof 42
Sort By:
International Journal of Hematology|February 24, 2001
Acute myeloid leukemia in adults: is postconsolidation maintenance therapy necessary?T Büchner, W Hiddemann, B Wörmann, et al.
Clinical Cardiology|February 28, 2007
Coronary microvascular reactivity is only partially predicted by atherosclerosis risk factors or coronary artery disease in women evaluated for suspected ischemia: results from the NHLBI Women's Ischemia Syndrome Evaluation (WISE)Timothy R Wessel, Christopher B Arant, Susan P McGorray, et al.
Journal of the American College of Cardiology|February 7, 2006
The value of estimated functional capacity in estimating outcome: results from the NHBLI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) StudyLeslee J Shaw, Marian B Olson, Kevin Kip, et al.
Cardiovascular Diagnosis and Therapy|September 10, 2013
Left Ventricular Energy Model Predicts Adverse Events in Women With Suspected Myocardial Ischemia: Results From The NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) StudyMark Doyle, Nicole Weinberg, Gerald M Pohost, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 3, 2023
Landscape dynamics and diversification of the megadiverse South American freshwater fish faunaFernanda A S Cassemiro, James S Albert, Alexandre Antonelli, et al.
Cancer Chemotherapy and Pharmacology|October 6, 2001
Remission induction therapy: the more intensive the better?T Büchner, W Hiddemann, W Berdel, et al.
JAMA|June 7, 2006
Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trialVictor G Vogel, Joseph P Costantino, D Lawrence Wickerham, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 21, 2010
Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing breast cancerVictor G Vogel, Joseph P Costantino, D Lawrence Wickerham, et al.
JACC. Cardiovascular Imaging|October 16, 2010
Prognostic value of global MR myocardial perfusion imaging in women with suspected myocardial ischemia and no obstructive coronary disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) studyMark Doyle, Nicole Weinberg, Gerald M Pohost, et al.
Zootaxa|April 2, 2020
Poor taxonomic sampling undermines nomenclatural stability: A reply to Roxo <em>et al. (2019)</strong>Roberto E Reis, Heraldo A Britski, Marcelo R Britto, et al.
Pageof 42

Showing results (391-400 of 415) with videos related to

Sort By:
Pageof 42
International Journal of Hematology|February 24, 2001
Acute myeloid leukemia in adults: is postconsolidation maintenance therapy necessary?T Büchner, W Hiddemann, B Wörmann, et al.
Clinical Cardiology|February 28, 2007
Coronary microvascular reactivity is only partially predicted by atherosclerosis risk factors or coronary artery disease in women evaluated for suspected ischemia: results from the NHLBI Women's Ischemia Syndrome Evaluation (WISE)Timothy R Wessel, Christopher B Arant, Susan P McGorray, et al.
Journal of the American College of Cardiology|February 7, 2006
The value of estimated functional capacity in estimating outcome: results from the NHBLI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) StudyLeslee J Shaw, Marian B Olson, Kevin Kip, et al.
Cardiovascular Diagnosis and Therapy|September 10, 2013
Left Ventricular Energy Model Predicts Adverse Events in Women With Suspected Myocardial Ischemia: Results From The NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) StudyMark Doyle, Nicole Weinberg, Gerald M Pohost, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 3, 2023
Landscape dynamics and diversification of the megadiverse South American freshwater fish faunaFernanda A S Cassemiro, James S Albert, Alexandre Antonelli, et al.
Cancer Chemotherapy and Pharmacology|October 6, 2001
Remission induction therapy: the more intensive the better?T Büchner, W Hiddemann, W Berdel, et al.
JAMA|June 7, 2006
Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trialVictor G Vogel, Joseph P Costantino, D Lawrence Wickerham, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 21, 2010
Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing breast cancerVictor G Vogel, Joseph P Costantino, D Lawrence Wickerham, et al.
JACC. Cardiovascular Imaging|October 16, 2010
Prognostic value of global MR myocardial perfusion imaging in women with suspected myocardial ischemia and no obstructive coronary disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) studyMark Doyle, Nicole Weinberg, Gerald M Pohost, et al.
Zootaxa|April 2, 2020
Poor taxonomic sampling undermines nomenclatural stability: A reply to Roxo <em>et al. (2019)</strong>Roberto E Reis, Heraldo A Britski, Marcelo R Britto, et al.
Pageof 42